7th Drug Formulation, Solubility & Bioavailability – 7th Drug Formulation, Solubility & Bioavailability
When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation and delivery strategies to maximize bioavailability. ExL’s 7th Drug Formulation, Solubility & Bioavailability conference helps you recognize the precise thresholds where an enabled formulation becomes necessary, as well as determine which method to use and how to predict and gauge its success. This event provides you with an unmatched focus on the latest technologies and team skills that you need to gather and interpret first-in-human results and accelerate time-to-market.
Top Five Reasons to Attend
New frontiers in virtual and ultra-rapid drug development
Deeper understanding of self-association to enhance formulation performance
Strategies to design, interpret and rank the performance of the next generation of predictive models
Skills for getting long-term stability answers in the shortest time possible
Latest insights on continuous manufacturing for enabled formulations
FULL-DAY SEMINAR ON ADVANCES IN DRUG DELIVERY: Featuring oral biologics, long-acting injectables, amorphous biologics, depot microparticles, targeted tissue delivery – and much more!
Who Should Attend
This event is designed for pharmaceutical, biotech and medical device professionals responsible for the following areas: